Oral hydralazine therapy for chronic mitral regurgitation in the dog.
D000284:Administration, Oral; D000818:Animals; D002302:Cardiac Output / Q000187:drug effects; D002908:Chronic Disease; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006830:Hydralazine / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008944:Mitral Valve Insufficiency / Q000188:drug therapy / Q000662:veterinary*; D010101:Oxygen Consumption / Q000187:drug effects; D011654:Pulmonary Edema / Q000188:drug therapy / Q000662:veterinary; D014882:Water-Electrolyte Balance / Q000187:drug effects
D006830:Hydralazine